Extranodal multifocal Rosai-Dorfman disease: Response to 2-chlorodeoxyadenosine treatment

International Journal of Hematology

Volumn 89, Issue 1, 2009, Pages 58-62

  Konca, Ceyla ^a   Özkurt, Zübeyde N ^a   Deger, Müge ^a   Akı, Zeynep ^a   Yağcı, Münci ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

2 chlorodeoxyadenosine; Extranodal; PET; Rosai Dorfman disease

Indexed keywords

CLADRIBINE; DEXAMETHASONE; FLUORODEOXYGLUCOSE F 18;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; LABORATORY TEST; LYMPH NODE BIOPSY; MALE; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; ROSAI DORFMAN DISEASE; SHORT COURSE THERAPY; SPINAL CORD COMPRESSION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 67349123971     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0192-2     Document Type: Article

References (37)

1. J Rosai RF Dorfman 1969 Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity Arch Pathol 87 1 63 70
2. DM Becroft 1973 Benign sinus histiocytosis with massive lymphadenopathy: transient immunological defects in a child with mediastinal involvement J Clin Pathol 26 7 463 9 10.1136/jcp.26.7.463
3. J Rosai RF Dorfman 1972 Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases Cancer 30 5 1174 88 10.1002/1097-0142(197211)30:5<1174::AID-CNCR2820300507>3.0.CO;2-S
4. A Kugler 1997 Unusual bilateral renal histiocytosis: extranodal variant of Rosai-Dorfman disease J Urol 157 3 942 10.1016/S0022-5347(01)65089-4
5. A Krishnan A Nassar PT Nieh 2005 Rosai-Dorfman disease presenting as extranodal renal mass Urology 66 6 1319 10.1016/j.urology.2005.06.103
6. K Al-Saad 2005 Extranodal Rosai-Dorfman disease with multifocal bone and epidural involvement causing recurrent spinal cord compression Pediatr Dev Pathol 8 5 593 8 10.1007/s10024-005-8102-6
7. A Pulsoni 2002 Treatment of sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a case and literature review Am J Hematol 69 1 67 71 10.1002/ajh.10008
8. C Hargett T Bassett 2005 Atypical presentation of sinus histiocytosis with massive lymphadenopathy as an epidural spinal cord tumor: a case presentation and literature review J Spinal Disord Tech 18 2 193 6 10.1097/01.bsd.0000137156.44689.c0
9. E Foucar J Rosai R Dorfman 1990 Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): review of the entity Semin Diagn Pathol 7 1 19 73
10. IS Lossos 1997 Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a patient with isolated renotesticular involvement after cure of non-Hodgkin's lymphoma Ann Hematol 74 1 41 4 10.1007/s002770050254
11. H Shoda 2004 Sinus histiocytosis with massive lymphadenopathy associated with malignant lymphoma Intern Med 43 8 741 5 10.2169/internalmedicine.43.741
12. D Lu 2000 Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the same lymph node: a report of four cases and review of the literature Mod Pathol 13 4 414 9 10.1038/modpathol.3880071
13. R Kubota 1992 Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography J Nucl Med 33 11 1972 80
14. C Menzel 2003 PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging Arch Dermatol Res 295 7 280 3 10.1007/s00403-003-0431-6
15. JQ Yu 2004 Demonstration of increased FDG activity in Rosai-Dorfman disease on positron emission tomography Clin Nucl Med 29 3 209 10 10.1097/01.rlu.0000114018.07676.15
16. R Lim 2004 FDG PET of Rosai-Dorfman disease of the thymus AJR Am J Roentgenol 182 2 514
17. EM Baildam 1992 Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to acyclovir J R Soc Med 85 3 179 80
18. CC Chan CY Chu 2006 Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance Arch Dermatol 142 4 428 30 10.1001/archderm.142.4.428
19. J Giudicelli 1994 Destombes-Rosai-Dorfman syndrome: 2 uncommon clinical forms Rev Med Interne 15 12 834 7 10.1016/S0248-8663(05)82841-3
20. E Foucar J Rosai RF Dorfman 1978 Sinus histiocytosis with massive lymphadenopathy Arch Otolaryngol 104 12 687 93
21. S Ocheni 2007 Usefulness of oral corticosteroid in Rosai-Dorfman disease Eur J Cancer Care Engl 16 3 286 8 10.1111/j.1365-2354.2006.00746.x
22. G Sita 1996 Rosai-Dorfman syndrome with extranodal localizations and response to glucocorticoids: a case report Haematologica 81 2 165 7
23. V Raveenthiran 2003 Rosai-Dorfman disease: report of a 3-year-old girl with critical review of treatment options Eur J Pediatr Surg 13 5 350 4 10.1055/s-2003-43578
24. L Palomera 1997 Sinus histiocytosis with massive lymphadenopathy: complete response to low-dose interferon-alpha J Clin Oncol 15 5 2176
25. AR Silvers PM Som RJ Meyer 1996 Egg shell nodal calcification in a patient with sinus histiocytosis with massive lymphadenopathy treated with interferon AJNR Am J Neuroradiol 17 2 361 3
26. A Mebazaa 2007 Extensive purely cutaneous Rosai-Dorfman disease responsive to acitretin Int J Dermatol 46 11 1208 10 10.1111/j.1365-4632.2007. 03234.x
27. LY Chang TT Kuo HL Chan 2002 Extranodal Rosai-Dorfman disease with cutaneous, ophthalmic and laryngeal involvement: report of a case treated with isotretinoin Int J Dermatol 41 12 888 91 10.1046/j.1365-4362.2002.01675.x
28. JW Tjiu CH Hsiao TF Tsai 2003 Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment Br J Dermatol 148 5 1060 1 10.1046/j.1365-2133.2003. 05311.x
29. J Utikal 2007 Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses Arch Dermatol 143 6 736 40 10.1001/archderm.143.6.736
30. JM Pagel 2007 Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) Am J Hematol 82 12 1121 2 10.1002/ajh.21024
31. G Horneff 1996 Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): response to methotrexate and mercaptopurine Med Pediatr Oncol 27 3 187 92 10.1002/(SICI)1096-911X(199609)27:3<;187::AID-MPO10>;3. 0.CO;2-D
32. Y Jabali V Smrcka J Pradna 2005 Rosai-Dorfman disease: successful long-term results by combination chemotherapy with prednisone, 6-mercaptopurine, methotrexate, and vinblastine: a case report Int J Surg Pathol 13 3 285 9 10.1177/106689690501300311
33. S Inoue N Onwuzurike 2005 Venorelbine and methotrexate for the treatment of Rosai-Dorfman disease Pediatr Blood Cancer 45 1 84 5 10.1002/pbc.20361
34. M Tasso 2006 Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) treated with 2-chlorodeoxyadenosine Pediatr Blood Cancer 47 5 612 5 10.1002/pbc.20668
35. C Rodriguez-Galindo 2002 Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine Am J Hematol 69 3 179 84 10.1002/ajh.10053
36. C Rodriguez-Galindo 2004 Extranodal Rosai-Dorfman disease in children J Pediatr Hematol Oncol 26 1 19 24 10.1097/00043426-200401000-00007
37. A Aouba 2006 Dramatic clinical efficacy of cladribine in Rosai-Dorfman disease and evolution of the cytokine profile: towards a new therapeutic approach Haematologica 91 12 Suppl. ECR52